Company intelligence / Profile preview

Goldsol

St. Louis (Saint Louis), Missouri, United Statesgoldsol.en.made-in-china.com ↗

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Gold Biotechnology provides high-quality molecular biology grade reagents for cell and molecular biology research. The company has been serving academic and industry researchers globally for over thirty years with products such as luciferin, growth factors, antibiotics, enzymes, and DNA/protein research tools. No clinical results or therapeutic pipeline as it is not a drug developer.

Modalities: Research reagents (e.g., luciferin, growth factors, antibiotics, enzymes)
Industry: Chemicals & Materials

Partnerships

None publicly disclosed

Beyond the preview

Go deeper on Goldsol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldsol.

Explore the full profile